Pharmacy Times March 3, 2025
Key Takeaways
- The FDA’s annual flu vaccine meeting was canceled without rescheduling, raising concerns about future vaccine policy decisions.
- The CDC’s “Wild to Mild” campaign, aimed at promoting flu vaccination, was canceled, potentially increasing vaccine hesitancy.
- Robert F. Kennedy, Jr.’s leadership has led to doubts about vaccine efficacy, despite evidence supporting flu vaccine effectiveness.
- Rising influenza-associated morbidity and mortality highlight the need for continued public health education and accurate vaccine information.
The decisions were made amid the United States worst flu outbreak in over 2 decades.
The cancellation of key public health initiatives by the FDA and CDC has sparked concerns among health care leaders, highlighting the growing instability within federal health agencies under Robert F. Kennedy, Jr.’s...